Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Feb;50(2):108-12.
doi: 10.1310/hpj5002-108.

The role of subcutaneous ketorolac for pain management

Mary E Vacha  1 , Wennie Huang  2 , Jennifer Mando-Vandrick  2
Affiliations

The role of subcutaneous ketorolac for pain management

Mary E Vacha et al. Hosp Pharm. 2015 Feb.

Abstract

This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to jgeneral@ku.edu.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Gillis JC, Brogden RN.Ketorolac – A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management. Drugs. 1997;53:139–188. - PubMed
    1. Ripamonti C, Bandieri E.Pain therapy. Crit Rev Oncol Hematol. 2009;70:145–159. - PubMed
    1. Strom BL, Berlin JA, Kinman JL, et al. Parenteral ketorolac and risk of gastrointestinal and operative site bleeding: A postmarketing surveillance study. JAMA. 1996;275:376–382. - PubMed
    1. Ketorolac tromethamine injection, solution [product information]. Lake Forest, IL: Hospira, Inc; June2011.
    1. Parsons HA, Shukkoor A, Quan H, et al. Intermittent subcutaneous opioids for the management of cancer pain. J Palliat Med. 2008;11:1319–1324. - PMC - PubMed